Detection of the Challenging mutations at 1% VAF and 50 ng DNA input. by Lizhi Yu (12476136)

YTX treatment decreases tumour development in the B16F10 melanoma mouse model. by Araceli Tobío (3545306)

The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

Decreases in muscle size, muscle force, and TB mass in 3-mo Lmna^HSA-cko mice. by Lei Xiong (334812)

Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs. by Yang Zhang (30734)

IC₅₀s data of antimalarials against controls. by Winnie Okore (14139712)

Subjects:

Resveratrol treatment decreases SIRT1 and SIRT2 levels. by Mehtap Kilic Eren (591048)

Inhibition of TMEM16A decreased SW620 cell migration and invasion. by Yujie Sui (549090)

sEH inhibition decreased 16-week HF-diet–induced activation of inflammatory pathways in the liver. by Yan Liu (25061)

Imatinib or masitinib decreases cell surface expression of mature c-Kit in UT-7/Epo cell line. by Diane D'allard (405441)

Translocation of EHEC-Hly to mitochondria results in cytosolic cytochrome c release and ΔΨ_m decrease. by Martina Bielaszewska (79970)

“…<p>(<b>A, B</b>) HBMEC (<b>A</b>) and Caco-2 cells (<b>B</b>) were incubated for the times indicated with EHEC-Hly-containing OMVs TA50 or 8033 (20 µg of OMV protein containing 100 ng of EHEC-Hly) or with corresponding protein amounts of EHEC-Hly-negative OMVs TA51 or 8033c or left untreated (control). …”

A decrease in CD44+ cells in response to hypoxia. by Daniel V. Brown (3797809)

U87MG glioma cells transduced with gal-3 shRNA demonstrate decreased tumor size and growth. by Rafael Yamashita Ikemori (698128)

Drugs IC₅₀s data during the study period. by Winnie Okore (14139712)

Subjects:

ALK2 AON-induced exon skipping decreased BMP signaling in 2H11 endothelial cells. by SongTing Shi (430629)

TMEM16A knockdown induced a decrease in proliferation of SW620 cells. by Yujie Sui (549090)

SNPs IC₅₀s data at codon 876 during the study period. by Winnie Okore (14139712)

Subjects:

FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

“…When tumors reached an average of 150 mm³, mice were randomized to receive vehicle (ORA-Plus, 50 μL, n = 7) or FTY720 (10 mg/kg body weight/day in ORA-Plus, 50 μL, n = 7) by oral gavage for 16 days. …”

Conditional <i>Aff4</i> knockout decreases fat mass in mice. by Yaqian Chen (1711576)

IL-1β induced a decrease in TER values. by Tadayoshi Konno (3350282)